Not long after President Trump made his statement, Kenvue and Johnson & Johnson got into another complicated legal mess when ...
Kenvue stock share price today shows a major surge after Kimberly-Clark announced plans to buy Kenvue for over $40 billion.
The announcement comes just weeks after President Trump publicly spread debunked claims that Tylenol consumption is linked to autism.
Kimberly-Clark N/A said on Monday it will acquire Tylenol maker Kenvue KVUE-N +0.91% in a deal valued at about ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive ...